What 6 Analyst Ratings Have To Say About Taysha Gene Therapies Analysts have provided the following ratings for Taysha Gene Therapies (NASDAQ:TSHA) within the last quarter: Benzinga · Apr 1, 2022
Recap: Taysha Gene Therapies Q4 Earnings Taysha Gene Therapies (NASDAQ:TSHA) reported its Q4 earnings results on Thursday, March 31, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Benzinga · Mar 31, 2022
Taysha Gene Therapies's Earnings Outlook Taysha Gene Therapies (NASDAQ:TSHA) is set to give its latest quarterly earnings report on Thursday, 2022-03-31. Here's what investors need to know before the announcement. Analysts estimate that Taysha Gene Therapies will report an earnings per share (EPS) of $-1.25. Benzinga · Mar 30, 2022
Taysha Gene Therapies Earnings Conference Call Is Coming Up, Here's What You Need To Know Taysha Gene Therapies (NASDAQ:TSHA) will host a conference call at 08:00 AM ET on March 31, 2022, to discuss Q4 2021 earnings results. Benzinga · Mar 25, 2022